Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: In vitro-in vivo evaluation

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 6, 2000, Pages 435-443

  Dogru, S T ^a   Çalis, Sema ^a   Oner F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Calcitonin; Oral emulsion; Protease inhibitor; Rat model; w o w emulsion

Indexed keywords

APROTININ; DRUG CARRIER; SALCATONIN;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; DIALYSIS; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG TOLERABILITY; EMULSION; FEMALE; HYPERCALCEMIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOPOROSIS; PAGET BONE DISEASE; RAT;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; APROTININ; CALCITONIN; CHEMISTRY, PHARMACEUTICAL; DRUG INTERACTIONS; DRUG STABILITY; EMULSIONS; FEMALE; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SALMON;

EID: 0034527796     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00306.x     Document Type: Article

References (32)

1. Formation and applications of multiple emulsions
2. Obtaining multiple emulsions
3. Oral multiple W/O/W emulsion formulations for recombinant human insulin
4. W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: Biological activity after oral administration to normal and diabetic rats
5. Effect of non-ionic surfactant concentration and stability of w/o/w multiple emulsions: Microscopic and conductometric evaluation
6. Formation of w/o/w emulsions through the simple agitation of oil-water mixtures
7. An attempt at preparing water-in-oil-in-water multiple phase emulsions
8. Multiple emulsions as targetable delivery systems
9. Moisturizing substances entrapped in W/O/W emulsions: Analytical methodology for formulation, stability and release studies
10. A stable W/O/W multiple emulsion
11. Systemic delivery of therapeutic peptides and proteins
12. Effect of matrix characteristics on the in vitro release of calcitonin from PLGA microspheres
13. In vitro investigation into the enhancement of intestinal peptide absorption by emulsion systems
14. High adsorption capacity of sCT to PLGA microspheres
15. Development of a controlled peptide delivery system: Release behavior of sCT from PLGA microspheres of different matrix characteristics
16. Recent progress in protein and peptide delivery by noninvasive routes
17. The role of calcitonin in the development and treatment of osteoporosis
18. Drugs used in the treatment of metabolic bone diseases
19. Degradation pathways of salmon calcitonin in aqueous solution
20. Pharmacology and therapeutic use of calcitonin
21. The effect of nasal hCT on bone turnover in Paget's disease of bone implications for the treatment of other metabolic bone diseases
22. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In vitro permeability and in vivo oral absorption of salmon calcitonin
23. Adsorption of salmon calcitonin to PLGA microspheres
24. Degradation of synthetic salmon calcitonin in aqueous solution
25. The formulation and stability of multiple emulsions
26. Calcium measurements in serum and plasma: Total and ionize
27. Analytical reviews in clinical biochemistry: Calcium measurement
28. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats
29. Recent progress in protein and peptide delivery by noninvasive routes
30. Penetration and enzymatic barriers to peptide and protein absorption
31. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G)